TCM
UTHR icon

Tributary Capital Management’s United Therapeutics UTHR Stock Holding History

Tributary Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-730
Closed -$433K – 175
2026
Q1 		$433K Sell
730
-30
-4% -$14.9K 0.04% 130
2025
Q4 		$370K Sell
760
-325
-30% -$151K 0.04% 142
2025
Q3 		$455K Sell
1,085
-40
-4% -$13.5K 0.04% 133
2025
Q2 		$323K Hold
1,125
– – 0.03% 153
2025
Q1 		$347K Buy
1,125
+375
+50% +$129K 0.03% 145
2024
Q4 		$265K Sell
750
-50
-6% -$18.4K 0.02% 154
2024
Q3 		$287K Hold
800
– – 0.02% 157
2024
Q2 		$255K Buy
+800
New +$212K 0.02% 160
2016
Q2 		– Sell
-7,400
Closed -$825K – 195
2016
Q1 		$825K Sell
7,400
-2,500
-25% -$316K 0.13% 159
2015
Q4 		$1.55M Sell
9,900
-2,400
-20% -$349K 0.26% 123
2015
Q3 		$1.61M Sell
12,300
-8,600
-41% -$1.38M 0.27% 118
2015
Q2 		$3.64M Sell
20,900
-1,500
-7% -$270K 0.57% 78
2015
Q1 		$3.86M Sell
22,400
-9,591
-30% -$1.46M 0.6% 75
2014
Q4 		$4.14M Sell
31,991
-11,999
-27% -$1.55M 0.7% 62
2014
Q3 		$5.66M Sell
43,990
-2,400
-5% -$247K 1.19% 4
2014
Q2 		$4.11M Buy
46,390
+8,000
+21% +$769K 0.82% 38
2014
Q1 		$3.61M Hold
38,390
– – 0.76% 64
2013
Q4 		$4.34M Sell
38,390
-209
-0.5% -$18.8K 0.86% 26
2013
Q3 		$3.04M Buy
38,599
+13,748
+55% +$1M 0.63% 71
2013
Q2 		$1.64M Buy
+24,851
New +$1.6M 0.27% 169

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Tributary Capital Management's UTHR Position: Q2 2026 in Review

Tributary Capital Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 730 shares — an estimated $433K sold.

Tributary Capital Management first reported a position in UTHR in Q2 2013 and held it in 20 quarters. The position peaked at $5.66M in Q3 2014. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Tributary Capital Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Tributary Capital Management sold 730 United Therapeutics shares in Q2 2026, an estimated $433K.
  • Tributary Capital Management first reported a position in United Therapeutics in Q2 2013 and held it in 20 quarters.
  • Tributary Capital Management's United Therapeutics position peaked at $5.66M in Q3 2014.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Tributary Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.